A novel RNA sequencing-based miRNA signature predicts with recurrence and outcome of hepatocellular carcinoma.

However, this difference in recurrence frequency is marginally significant (chi‐square test, P = 0.06). 3.4.

also in 26,082 other papers

When the same analysis with these three clinical variables was applied to the training set and the testing set, Kaplan–Meier curves of the high‐ and low‐risk groups were notably different, although the difference did not reach statistical significance in some subgroups.

also in 111,027 other papers